Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea flag South Korea · Delayed Price · Currency is KRW
72,400
-3,600 (-4.74%)
At close: Feb 6, 2026

Next Biomedical Revenue

Next Biomedical had revenue of 4.93B KRW in the quarter ending September 30, 2025, with 125.07% growth. This brings the company's revenue in the last twelve months to 14.90B, up 70.64% year-over-year. In the year 2024, Next Biomedical had annual revenue of 9.54B with 95.46% growth.

Revenue (ttm)
14.90B
Revenue Growth
+70.64%
P/S Ratio
39.85
Revenue / Employee
n/a
Employees
n/a
Market Cap
593.96B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.54B4.66B95.46%
Dec 31, 20234.88B2.09B74.67%
Dec 31, 20222.80B527.74M23.28%
Dec 31, 20212.27B6.63M0.29%
Dec 31, 20202.26B1.46B182.32%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
DRTECH120.30B
MEDIANA Co.,Ltd59.83B
L&K Biomed40.33B
ASTERASYS Co.,Ltd36.47B
Vuno Inc.34.69B
Hironic33.18B
SELVAS Healthcare29.79B
Remed24.26B
Revenue Rankings